Looks like you’re on the UK site. Choose another location to see content specific to your location
RightEye’s vision system receives FDA approval
The RightEye eye-tracking system uses advanced eye-tracking technology and analytics and is thought to be the first of its kind to be approved by the FDA to record, view and analyse eye movements to facilitate identification of visual tracking impairment in patients by primary care optometrists, rehabilitation facilities, professional sports teams and the US military.
The system comes with RightEye EyeQ tests, reports and training tools, can be used in the following applications:
– RightEye functional vision test will enable to rapidly and objectively detect various functional vision issues that affect quality of life and automatically suggests computer-based exercises patients can do at home.
– RightEye Reading EyeQ will track reading proficiency in real time and helps to identify hidden vision issues associated with learning difficulties.
– RightEye Sports Vision EyeQ will identify opportunities to strengthen performance-related aspects of vision, and Sports Vision Trainer provides personalized exercises to athletes looking to enhance coordination and reaction times.
– RightEye Brain Health EyeQ will determine the severity levels of vision skill problems and their impact on brain performance. In addition, it offers computer-based vision exercises to solve oculomotor issues.
Adam Gross, RightEye co-founder and CEO said: “RightEye is committed to providing innovative, proven eye-tracking solutions that empower doctors to differentiate and expand their practices while transforming the lives of their patients through improved health and wellness. As we continue to pioneer the field of eye-tracking technology, we’ll advance the science and discover new solutions and applications that will benefit patients and doctors alike.”
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard